T-cell acute lymphoblastic leukemia pediatric · 3 regimens
Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
Mercaptopurine, Methotrexate, Vincristine Variant #02 | — | R 2 001 | 56d | — | — | ~2 | ~R 4 002 indirect | — |
Methotrexate, Pegaspargase, Vincristine Partial | — | — | — | — | — | — | — | — |
Mercaptopurine, Methotrexate, Pegaspargase, Vincristine Partial | — | — | — | — | — | — | — | — |
3 of 3 regimens shown